庄天从, 张华捷, 李喆, 吕新军, 王传林, 马霄, 潘钏愉. 2019年福建省晋江市健康人群破伤风抗体调查[J]. 疾病监测, 2020, 35(6): 523-526. DOI: 10.3784/j.issn.1003-9961.2020.06.014
引用本文: 庄天从, 张华捷, 李喆, 吕新军, 王传林, 马霄, 潘钏愉. 2019年福建省晋江市健康人群破伤风抗体调查[J]. 疾病监测, 2020, 35(6): 523-526. DOI: 10.3784/j.issn.1003-9961.2020.06.014
Tiancong Zhuang, Huajie Zhang, Zhe Li, Xinjun Lyu, Chuanlin Wang, Xiao Ma, Chuanyu Pan. Investigation on tetanus antibody in healthy people in Jinjiang, Fujian province, 2019[J]. Disease Surveillance, 2020, 35(6): 523-526. DOI: 10.3784/j.issn.1003-9961.2020.06.014
Citation: Tiancong Zhuang, Huajie Zhang, Zhe Li, Xinjun Lyu, Chuanlin Wang, Xiao Ma, Chuanyu Pan. Investigation on tetanus antibody in healthy people in Jinjiang, Fujian province, 2019[J]. Disease Surveillance, 2020, 35(6): 523-526. DOI: 10.3784/j.issn.1003-9961.2020.06.014

2019年福建省晋江市健康人群破伤风抗体调查

Investigation on tetanus antibody in healthy people in Jinjiang, Fujian province, 2019

  • 摘要:
    目的了解福建省晋江市健康人群破伤风抗体(TAB)状况。
    方法采用分层随机抽样法,采集晋江市2019年各年龄段健康人群血清,通过酶联免疫吸附试验(ELISA)检测血清TAB水平。 使用Excel软件整理数据,运用SPSS 22.0软件进行不同组间TAB阳性率差异比较。
    结果775份调查样本中,TAB总体阳性率为39.2%(304/775),各年龄组TAB阳性率分别为71.9%(87/121,8~20岁)、53.6%(82/153,21~30岁)、39.3%(57/145,31~40岁)、25.2%(38/151,41~50岁)、16.2%(17/105,51~60岁)和23.0%(23/100,61岁以上);有含破伤风类毒素疫苗(TTCV)免疫史人群TAB阳性率为70.7%(164/232),无免疫史或免疫史不明人群TAB阳性率为25.8%(140/543);TAB阴性者从事破伤风高危行业和低危行业的人群,年龄组分布差异有统计学意义(χ2=62.185;P<0.000);破伤风高危行业人群中40~50岁年龄组比例为46.79%。
    结论晋江市健康人群TAB阳性率随年龄增长呈下降趋势,应重视开展TTCV的加强免疫工作。

     

    Abstract:
    ObjectiveTo determine tetanus antibody (TAB) levels of healthy population in Jinjiang city in 2019.
    MethodsWe collected the sera sample of healthy population at different age in 2019 by stratified random sampling, and detected TAB levels by enzyme-linked immunosorbent assay.
    ResultsThe overall positive rate of TAB among 775 subjects was 39.2% (304/775), and the positive rate of TAB in each age group was 71.9% (87/121, aged 8–20 years), 53.6% (82/153, aged 21–30 years), 39.3%(57/145, aged 31–40 years), 25.2% (38/151, aged 41–50 years), 16.2%(17/105, aged 51–60 years), and 23.0% (23/100, over 61 years old), respectively. The positive rate of TAB was 70.7% (164/232) in subjects who had been immunized with tetanus toxoid-containing vaccine (TTCV) in the past years, while 25.8% (140/543) in subjects without or with uncertain TTCV immunization history. For the TAB negative population, there was statistically significant difference in age group distribution between tetanus high-risk industries and tetanus low-risk industries ( χ2=62.185, P<0.000). People aged 41–50 years in tetanus high-risk industries accounted for 46.79%.
    ConclusionThe overall positive rate of TAB in healthy population decreased significantly with age. More attentions should be paid to enhance TTCV immunization.

     

/

返回文章
返回